ROBERTA KARLA BARBOSA DE SALES
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/09 - Laboratório de Pneumologia, Hospital das Clínicas, Faculdade de Medicina
LIM/09 - Laboratório de Pneumologia, Hospital das Clínicas, Faculdade de Medicina
7 resultados
Resultados de Busca
Agora exibindo 1 - 7 de 7
conferenceObject Brazilian Analysis of Lent Score: Predicting the Survival Rate of Malignant Pleural Effusion(2023) COLARES, P. F.; RIVAS, J. Delgado; BELON, C. E. F.; ACENCIO, M. M. P.; SALES, R. K.; TEIXEIRA, L. R.- Tuberculous empyema: combined intrapleural therapy might be an alternative(2022) COLARES, Philippe de Figueiredo Braga; RIVAS, Jennifer Kiara Delgado; SCIORTINO, Amanda dos Santos; SALES, Roberta Karla Barbosa de; TEIXEIRA, Lisete Ribeiro
conferenceObject Tuberculous Empyema: Combined Intrapleural Therapy Might Be an Alternative(2023) COLARES, P. F.; RIVAS, J. Delgado; SCIORTINO, A. D.; SAAVEDRA, N. Medina; SALES, R.; TEIXEIRA, L. R.- Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease(2023) SILVA, Denise Rossato; SANTOS, Ana Paula; VISCA, Dina; BOMBARDA, Sidney; DALCOLMO, Margareth Maria Pretti; GALVAO, Tatiana; MIRANDA, Silvana Spindola de; PARENTEL, Ana Alice Amaral Ibiapina; RABAHI, Marcelo Fouad; SALES, Roberta Karla Barbosa de; MIGLIORI, Giovanni Battista; MELLO, Fernanda Carvalho de QueirozHistorically, all efforts against tuberculosis were focused on rapid diagnosis and effective treatment to break the chain of transmission of Mycobacterium tuberculosis. However, in the last few years, more and more evidence has been found on the dramatic consequences of the condition defined as post-tuberculosis lung disease (PTLD). Approximately one third of patients surviving pulmonary tuberculosis face considerable ongoing morbidities, including respiratory impairment, psychosocial challenges, and reduced health-related quality of life after treatment completion. Given the important global and local burden of tuberculosis, as well as the estimated burden of PTLD, the development of a consensus document by a Brazilian scientific society-Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)-was considered urgent for the prevention and management of this condition in order to allocate resources to and within tuberculosis services appropriately and serve as a guide for health care professionals. A team of eleven pulmonologists and one methodologist was created by the SBPT to review the current evidence on PTLD and develop recommendations adapted to the Brazilian context. The expert panel selected the topics on the basis of current evidence and international guidelines. During the first phase, three panel members drafted the recommendations, which were divided into three sections: definition and prevalence of PTLD, assessment of PTLD, and management of PTLD. In the second phase, all panel members reviewed, discussed, and revised the recommendations until a consensus was reached. The document was formally approved by the SBPT in a special session organized during the 2023 SBPT Annual Conference.
conferenceObject Minute Pulmonary Meningothelial-like Nodules as an Incidental Finding in Lung Biopsy: Case Report(2023) COLARES, P. F.; RIVAS, J. Delgado; SCIORTINO, A. d.; SALES, R.; TEIXEIRA, L. R.- The challenge of tobacco and nicotine use among women(2023) CORREA, Paulo Cesar Rodrigues P.; SALES, Roberta Karla B. de; KNORST, Marli Maria; PINTO, Suzianne Ruth H. Lima; RAGNINI, Laura Fonseca Queiroz; TOURINHO, Cristiane Almeida Pires; STORRER, Karin Mueller; SCUARCIALUPI, Maria Enedina C. De A.; CASTELLANO, Maria Vera C. De O.; NETO, Aldo Agra De Albuquerque; RAVARA, Sofia Belo
- Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort(2023) CASCO, Nicolas; JORGE, Alberto Levi; PALMERO, Domingo Juan; ALFFENAAR, Jan-Willem; FOX, Greg J.; EZZ, Wafaa; CHO, Jin-Gun; DENHOLM, Justin; SKRAHINA, Alena; SOLODOVNIKOVA, Varvara; ARBEX, Marcos Abdo; ALVES, Tatiana; RABAHI, Marcelo Fouad; PEREIRA, Giovana Rodrigues; SALES, Roberta; SILVA, Denise Rossato; SAFFIE, Muntasir M.; SALINAS, Nadia Escobar; MIRANDA, Ruth Caamano; CISTERNA, Catalina; CONCHA, Clorinda; FERNANDEZ, Israel; VILLALON, Claudia; VERA, Carolina Guajardo; TAPIA, Patricia Gallegos; CANCINO, Viviana; CARBONELL, Monica; CRUZ, Arturo; MUNOZ, Eduardo; MUNOZ, Camila; NAVARRO, Indira; PIZARRO, Rolando; SANCHEZ, Gloria Pereira Cristina; RIQUELME, Maria Soledad Vergara; VILCA, Evelyn; SOTO, Aline; FLORES, Ximena; GARAVAGNO, Ana; BAHAMONDES, Martina Hartwig; MERINO, Luis Moyano; PRADENAS, Ana Maria; REVILLOT, Macarena Espinoza; RODRIGUEZ, Patricia; SALINAS, Angeles Serrano; TAIBA, Carolina; VALDES, Joaquin Farias; SUBIABRE, Jorge Navarro; ORTEGA, Carlos; PALMA, Sofia; CASTILLO, Patricia Perez; PINTO, Monica; BIDEGAIN, Francisco Rivas; VENEGAS, Margarita; YUCRA, Edith; LI, Yang; CRUZ, Andres; GUELVEZ, Beatriz; PLAZA, Regina Victoria; HOYOS, Kelly Yoana Tello; CARDOSO-LANDIVAR, Jose; BOOM, Martin Van Den; ANDREJAK, Claire; BLANC, Francois-Xavier; DOURMANE, Samir; FROISSART, Antoine; IZADIFAR, Armine; RIVIERE, Frederic; SCHLEMMER, Frederic; MANIKA, Katerina; DIALLO, Boubacar Djelo; HASSANE-HAROUNA, Souleymane; ARTILES, Norma; MEJIA, Licenciada Andrea; GUPTA, Nitesh; ISH, Pranav; MISHRA, Gyanshankar; PATEL, Jigneshkumar M.; SINGLA, Rupak; UDWADIA, Zarir F.; ALLADIO, Francesca; ANGELI, Fabio; CALCAGNO, Andrea; CENTIS, Rosella; CODECASA, Luigi Ruffo; LAURETIS, Angelo De; ESPOSITO, Susanna M. R.; FORMENTI, Beatrice; GAVIRAGHI, Alberto; GIACOMET, Vania; GOLETTI, Delia; GUALANO, Gina; MATTEELLI, Alberto; MIGLIORI, Giovanni Battista; MOTTA, Ilaria; PALMIERI, Fabrizio; PONTALI, Emanuele; PRESTILEO, Tullio; RICCARDI, Niccolo; SADERI, Laura; SAPORITI, Matteo; SOTGIU, Giovanni; SPANEVELLO, Antonio; STOCHINO, Claudia; TADOLINI, Marina; TORRE, Alessandro; VILLA, Simone; VISCA, Dina; KURHASANI, Xhevat; FURJANI, Mohammed; RASHEED, Najia; DANILA, Edvardas; DIKTANAS, Saulius; RIDAURA, Ruy Lopez; LOPEZ, Fatima Leticia Luna; TORRICO, Marcela Munoz; RENDON, Adrian; AKKERMAN, Onno W.; CHIZARAM, Onyeaghala; AL-ABRI, Seif; ALYAQUOBI, Fatma; ALTHOHLI, Khalsa; AGUIRRE, Sarita; TEIXEIRA, Rosarito Coronel; EGEA, Viviana De; IRALA, Sandra; MEDINA, Angelica; SEQUERA, Guillermo; SOSA, Natalia; VAZQUEZ, Fatima; LLANOS-TEJADA, Felix K.; MANGA, Selene; VILLANUEVA-VILLEGAS, Renzo; ARAUJO, David; DUARTE, Raquel; MARQUES, Tania Sales; GRECU, Victor Ionel; SOCACI, Adriana; BARKANOVA, Olga; BOGORODSKAYA, Maria; BORISOV, Sergey; MARIANDYSHEV, Andrei; KALUZHENINA, Anna; VUKICEVIC, Tatjana Adzic; STOSIC, Maja; BEH, Darius; NG, Deborah; ONG, Catherine W. M.; SOLOVIC, Ivan; DHEDA, Keertan; GINA, Phindile; CAMINERO, Jose A.; GALVAO, Maria Luiza De Souza; DOMINGUEZ-CASTELLANO, Angel; GARCIA-GARCIA, Jose-Maria; PINARGOTE, Israel Molina; FERNANDEZ, Sarai Quiros; SANCHEZ-MONTALVA, Adrian; HUGUET, Eva Tabernero; MURGUIONDO, Miguel Zabaleta; BART, Pierre-Alexandre; MAZZA-STALDER, Jesica; D'AMBROSIO, Lia; KAMOLWAT, Phalin; BAKKO, Freya; BARNACLE, James; BIRD, Sophie; BROWN, Annabel; CHANDRAN, Shruthi; KILLINGTON, Kieran; MAN, Kathy; PAPINENI, Padmasayee; RITCHIE, Flora; TIBERI, Simon; UTJESANOVIC, Natasa; ZENNER, Dominik; HEARN, Jasie L.; HEYSELL, Scott; YOUNG, LauraBackground Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19. Methods We collected data from 174 centres in 31 countries on all patients affected by COVID-19 and TB between 1 March 2020 and 30 September 2022. Patients were followed-up until cure, death or end of cohort time. All patients had TB and COVID-19; for analysis purposes, deaths were attributed to TB, COVID-19 or both. Survival analysis was performed using Cox proportional risk-regression models, and the log-rank test was used to compare survival and mortality attributed to TB, COVID-19 or both. Results Overall, 788 patients with COVID-19 and TB (active or sequelae) were recruited from 31 countries, and 10.8% (n=85) died during the observation period. Survival was significantly lower among patients whose death was attributed to TB and COVID-19 versus those dying because of either TB or COVID-19 alone (p<0.001). Significant adjusted risk factors for TB mortality were higher age (hazard ratio (HR) 1.05, 95% CI 1.03-1.07), HIV infection (HR 2.29, 95% CI 1.02-5.16) and invasive ventilation (HR 4.28, 95% CI 2.34-7.83). For COVID-19 mortality, the adjusted risks were higher age (HR 1.03, 95% CI 1.02-1.04), male sex (HR 2.21, 95% CI 1.24-3.91), oxygen requirement (HR 7.93, 95% CI 3.44- 18.26) and invasive ventilation (HR 2.19, 95% CI 1.36-3.53). Conclusions In our global cohort, death was the outcome in >10% of patients with TB and COVID-19. A range of demographic and clinical predictors are associated with adverse outcomes.